Clinical Trial Update: Prevention of Hypertension: A Randomized Trial [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating prevention of hypertension sponsored by Northwestern University has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Disease
• Hypertension
• Vascular Diseases

Snippet

Sponsor: Northwestern University | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 3 | Status: COMPLETED